NF2 and neoplasm: It is now known that between 20–40% of sporadic schwannomas are inactivated by NF2 methylation [38,39] and in a similar fashion to TP16 this could involve both copies of NF2 and explain why some tumours do not harbour identifiable point mutations or LOH.